PROMISING RESEARCH ON ANTIVIRAL MEDICATIONS OFFERS NEW PROSPECTS FOR SARS-COV-2 RECOVERY
Anusha Gurram
, Bavitha Chagamreddy
, Jessica Tumukunde
, Lakshmi Venkata Supraja Kurapati
, Sri Sai Manoja Rasagna M.
, Druthima Chowdary Chigurupati
, Doppalapudi Pavani
and Reethika Singh Ranwas
- Department of Biotechnology, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India.
- Department of Molecular Biology, Cresent Biosciences, ICRAB Campus, Kanpur, Uttar Pradesh, India.
- Abstract
- Keywords
- Cite This Article as
- Corresponding Author
The ongoing COVID-19 pandemic has spurred extensive research efforts worldwide to identify effective treatments for SARS-CoV-2, the virus responsible for the disease. This study focusses on recent developments in antiviral medication research, showcasing the potential breakthroughs and novel approaches in the quest for SARS-CoV-2 recovery. From monoclonal antibodies to emerging antiviral drugs and vaccine advancements, this research landscape offers renewed hope for managing and ultimately defeating the virus. We summarize the key findings, promising prospects, and evolving strategies in the field of antiviral therapeutics, underscoring the collective efforts to combat the global pandemic.
[Anusha Gurram, Bavitha Chagamreddy, Jessica Tumukunde, Lakshmi Venkata Supraja Kurapati, Sri Sai Manoja Rasagna M., Druthima Chowdary Chigurupati, Doppalapudi Pavani and Reethika Singh Ranwas (2023); PROMISING RESEARCH ON ANTIVIRAL MEDICATIONS OFFERS NEW PROSPECTS FOR SARS-COV-2 RECOVERY Int. J. of Adv. Res. 11 (Oct). 250-253] (ISSN 2320-5407). www.journalijar.com
Cresent Biosciences
India
